Transition From Distinct Types of KRAS Mutation-Harboring Multifocal Lung Adenocarcinoma to Rhabdoid Tumor: A Longitudinal Follow-Up

Kensuke Setoguchi; Shigehisa Yanagi; Toshihiro Gi; Hironobu Tsubouchi; Kazuko Uto; Takafumi Shigekusa; Nobuhiro Matsumoto; Yuichiro Sato; Masamitsu Nakazato

doi:10.12659/AJCR.932452

25 August 2021 : Case report Japan

Transition From Distinct Types of KRAS Mutation-Harboring Multifocal Lung Adenocarcinoma to Rhabdoid Tumor: A Longitudinal Follow-Up

Challenging differential diagnosis, Rare disease

Kensuke Setoguchi^1ABCDEF, Shigehisa Yanagi^1ABCDEFG*, Toshihiro Gi

^2ADE, Hironobu Tsubouchi^1AE, Kazuko Uto^1ABCDEF, Takafumi Shigekusa

^1ABE, Nobuhiro Matsumoto

^1AE, Yuichiro Sato^3AE, Masamitsu Nakazato^1AE

DOI: 10.12659/AJCR.932452

Am J Case Rep 2021; 22:e932452

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 6. Immunohistochemical findings of SMARCA4 (BRG1, A–C). Both adenocarcinoma cells (B) and rhabdoid tumor cells (C) retained nuclear expression of SMARCA4. A: 100×; B, C: 200× magn.

Back to the Article

Transition From Distinct Types of KRAS Mutation-Harboring Multifocal Lung Adenocarcinoma to Rhabdoid Tumor: A Longitudinal Follow-Up

Your Privacy